J&J Risperdal, Topamax Are Candidates For Alza Drug Delivery Systems

Johnson & Johnson's antipsychotic Risperdal and anti-epileptic agent Topamax are candidates for product life extension through Alza's drug delivery technology (especially the OROS osmotic system), Alza Pharmaceuticals Group VP Samuel Saks, MD, told analysts March 27.

More from Archive

More from Pink Sheet